Form4insider filings, from the source

SEC Form 4 · accession 0000932440-17-000034

EAGLE PHARMACEUTICALS, INC. · EGRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jay Moorin
10% Owner
Period of report
Apr 25, 2017
Accepted (ET)
Apr 27, 2017 · 4:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000827871

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock $0.001 par valueF2Apr 25, 2017M2,340$0.90A9,117IBy ProQuest Financial LLC
Common Stock $0.001 par valueF2Apr 25, 2017M2,340$4.04A11,457IBy ProQuest Financial LLC
Common Stock $0.001 par valueF2Apr 25, 2017M2,340$8.78A13,797IBy ProQuest Financial LLC
Common Stock $0.001 par valueF2Apr 25, 2017M2,340$8.78A16,137IBy ProQuest Financial LLC
Common Stock $0.001 par valueF2Apr 25, 2017M2,340$8.78A18,477IBy ProQuest Financial LLC
Common Stock $0.001 par valueF2Apr 25, 2017M3,120$4.42A21,597IBy ProQuest Financial LLC
Common Stock $0.001 par valueF2Apr 25, 2017M9,360$12.67A30,957IBy ProQuest Financial LLC
Common Stock $0.001 par valueF2Apr 25, 2017M10,000$46.09A40,957IBy ProQuest Financial LLC
Common Stock $0.001 par valueF2Apr 25, 2017M20,000$59.31A60,957IBy ProQuest Financial LLC
Common Stock $0.001 par valueF3,F2Apr 25, 2017S51,219$88.34D9,738IBy ProQuest Financial LLC
Common Stock $0.001 par valueF4,F2Apr 25, 2017S2,961$89.09D6,777IBy ProQuest Financial LLC
Common Stock $0.001 par valueF1holding———3,584,087IBy ProQuest Investments IV, L.P.
Common Stock $0.001 par valueholding———23,274IBy Jay Moorin through IRA

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy)F2$0.90Apr 25, 2017M2,340DMar 6, 2012Jun 29, 2017Common Stock $0.001 par value2,3400I
Stock Option (right to buy)F2$4.04Apr 25, 2017M2,340DMar 6, 2013Jun 29, 2017Common Stock $0.001 par value2,3400I
Stock Option (right to buy)F2$8.78Apr 25, 2017M2,340DMar 6, 2014Jun 29, 2017Common Stock $0.001 par value2,3400I
Stock Option (right to buy)F2$8.78Apr 25, 2017M2,340DJul 12, 2015Jun 29, 2017Common Stock $0.001 par value2,3400I
Stock Option (right to buy)F2$8.78Apr 25, 2017M2,340DJun 29, 2016Jun 29, 2017Common Stock $0.001 par value2,3400I
Stock Option (right to buy)F2$4.42Apr 25, 2017M3,120DJun 29, 2016Jun 29, 2017Common Stock $0.001 par value3,1200I
Stock Option (right to buy)F2$12.67Apr 25, 2017M9,360DApr 8, 2015Jun 29, 2017Common Stock $0.001 par value9,3600I
Stock Option (right to buy)F2$46.09Apr 25, 2017M10,000DMar 13, 2016Jun 29, 2017Common Stock $0.001 par value10,0000I
Stock Option (right to buy)F2$59.31Apr 25, 2017M20,000DApr 21, 2016Jun 29, 2017Common Stock $0.001 par value20,0000I

Explanation of responses